Bionano Genomics (BNGO) closed at $1.00 on November 13, 2026, down 3.8% from the previous close, on volume of 553,859 shares (30-day average 237,062).
Data as of November 13, 2026.
Bionano Genomics reports Q3 results
Seeking Alpha News (Tue, 10-Nov 4:06 PM ET)
Bionano Reports Third Quarter 2026 Results and Provides a Business Update
Globe Newswire (Tue, 10-Nov 4:05 PM ET)
Here are the major earnings after the close Tuesday
Seeking Alpha News (Tue, 10-Nov 10:00 AM ET)
These Are the Stocks Reporting Earnings Today – November 10, 2026
TipRanks (Tue, 10-Nov 4:30 AM ET)
Bionano Genomics Q3 2026 Earnings Preview
Seeking Alpha News (Mon, 9-Nov 5:35 PM ET)
TipRanks (Mon, 9-Nov 1:04 PM ET)
TipRanks (Mon, 9-Nov 1:04 PM ET)
Globe Newswire (Tue, 27-Oct 4:05 PM ET)
Globe Newswire (Wed, 23-Sep 9:00 AM ET)
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes. Geographically, it operates in the Americas, EMEA, and Asia Pacific, of which the EMEA region generates the majority of its revenue. It generates product revenue from sales of its OGM and Ionic Purification systems and consumables, which include its instruments and their VIA software.
Bionano Genomics trades on the NASDAQ stock market under the symbol BNGO.
As of November 13, 2026, BNGO stock price declined to $1.00 with 553,859 million shares trading.
BNGO has a beta of 1.30, meaning it tends to be more sensitive to market movements. BNGO has a correlation of 0.07 to the broad based SPY ETF.
BNGO has a market cap of $13.98 million. This is considered a Sub-Micro Cap stock.
Last quarter Bionano Genomics reported $8 million in Revenue and -$.54 earnings per share. This fell short of revenue expectation by $-158,400 and missed earnings estimates by -$.07.
In the last 3 years, BNGO traded as high as $136.20 and as low as $.97.
The top ETF exchange traded funds that BNGO belongs to (by Net Assets): VXF.
BNGO has underperformed the market in the last year with a price return of -37.5% while the SPY ETF gained +11.5%. BNGO has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -16.7% and -16.7%, respectively, while the SPY returned -2.1% and -1.9%, respectively.
BNGO support price is $.99 and resistance is $1.09 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that BNGO shares will trade within this expected range on the day.
